NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/23/2024
Back to search
Official data from USPTO
FANTASTIC FOOTIE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FANTASTIC FOOTIE
ST13
US500000086737413Class
25
Filing
86737413
Registration
5360405
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
10/23/2024
Trademark type
Word
Nice classes
25
Filing date
08/26/2015
Registration date
12/19/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/23/2024
Last transaction
10/23/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/08/2016
First use in commerce
02/08/2016
Drawing code
4
Owner type
16
Owner location
Durham, NC, US
Examiner
DALIER, JOHN DAVID
Current location
Historical data usage
Holders and representatives
Holders
Implus Footcare, LLC
Representatives
Richard S. Donnell Implus Footcare, LLC
Technical classification
Nice Classes
Class 25
Vienna Codes
No Vienna codes available.
Goods and services
Class 25
Insoles; socks
Publications
History of USPTO decisions and trademark events.
44 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/23/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/21/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
09/27/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/23/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
06/26/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/26/2024
E815
TEAS SECTION 8 & 15 RECEIVED
12/15/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/19/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/04/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/19/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/14/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/12/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/05/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/05/2017
IUAF
USE AMENDMENT FILED
10/20/2017
EISU
TEAS STATEMENT OF USE RECEIVED
10/20/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/09/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2017
PUBO
PUBLISHED FOR OPPOSITION
03/14/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/03/2017
ALIE
ASSIGNED TO LIE
01/11/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/15/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/15/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/15/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/17/2016
GNFR
FINAL REFUSAL E-MAILED
06/17/2016
CNFR
FINAL REFUSAL WRITTEN
06/17/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2015
GNRT
NON-FINAL ACTION E-MAILED
12/09/2015
CNRT
NON-FINAL ACTION WRITTEN
12/09/2015
DOCK
ASSIGNED TO EXAMINER
12/04/2015
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/05/2015
ALIE
ASSIGNED TO LIE
10/02/2015
ALIE
ASSIGNED TO LIE
09/25/2015
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/10/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/31/2015
NWAP
NEW APPLICATION ENTERED
08/29/2015
Continuous trademark protection
Get notified about every new filing that threatens FANTASTIC FOOTIE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.